CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
Authors
Keywords
HIV-associated neurocognitive disorders, Cerebrospinal fluid, Antiretrovirals, Pharmacokinetics, Pharmacodynamics, Compartmentalization
Journal
Current HIV/AIDS Reports
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-01-23
DOI
10.1007/s11904-018-0375-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychiatric Symptoms in Patients Receiving Dolutegravir
- (2017) Anna Fettiplace et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study
- (2017) Robert S Hogg et al. Lancet HIV
- Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
- (2016) Thomas M. Gates et al. AIDS
- A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
- (2016) Melanie Thompson et al. AIDS
- White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy
- (2016) Tanja Su et al. AIDS
- Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico , In Vitro , and In Vivo Investigation
- (2016) Paul Curley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients
- (2016) C Hoffmann et al. HIV MEDICINE
- Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy
- (2016) Albert M. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
- (2016) A. Calcagno et al. Journal of Neuroimmune Pharmacology
- CCR5 blockade for neuroinflammatory diseases — beyond control of HIV
- (2016) Guillaume Martin-Blondel et al. Nature Reviews Neurology
- Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
- (2016) Arvid Edén et al. PLoS One
- Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
- (2015) Jonathan Underwood et al. AIDS
- HIV-1 CNSin vitroinfectivity models based on clinical CSF samples
- (2015) Borja Mora-Peris et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cerebrospinal Fluid (CSF) CD8+ T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND)
- (2015) Rachel D. Schrier et al. PLoS One
- Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy
- (2015) Francesca Ferretti et al. Current HIV/AIDS Reports
- Differences in the Direction of Change of Cerebral Function Parameters Are Evident over Three Years in HIV-Infected Individuals Electively Commencing Initial cART
- (2015) Alan Winston et al. PLoS One
- HIV protease inhibitor exposure predicts cerebral small vessel disease
- (2014) Virawudh Soontornniyomkij et al. AIDS
- The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV
- (2014) E. R. Hammond et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility
- (2014) Massimiliano Fabbiani et al. ANTIVIRAL THERAPY
- Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-Infected Patients Are Associated With Compartmental Viral Control
- (2014) Andrea Calcagno et al. CLINICAL INFECTIOUS DISEASES
- ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects
- (2014) S. L. Letendre et al. CLINICAL INFECTIOUS DISEASES
- Controversies in HIV-associated neurocognitive disorders
- (2014) Sam Nightingale et al. LANCET NEUROLOGY
- Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues
- (2014) Amanda Clarke et al. Journal of the International AIDS Society
- Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART
- (2013) Lucy J. Garvey et al. AIDS
- Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
- (2013) Matteo Vassallo et al. AIDS
- Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
- (2013) Ronald J. Ellis et al. CLINICAL INFECTIOUS DISEASES
- In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir
- (2013) F. Canducci et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein
- (2013) T. P. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
- (2012) Michael J. Peluso et al. AIDS
- Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV
- (2012) Cecilia M Shikuma et al. ANTIVIRAL THERAPY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
- (2010) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
- (2010) K. R. Robertson et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now